{"nct_id":"NCT02337751","title":"A Phase 3, Long-term, Extension Study of TVP-1012 (1 mg) in Early Parkinson's Disease Participants","status":"COMPLETED","status_verified_date":"2022-02","start_date":"2015-07-10","start_date_type":"ACTUAL","primary_completion_date":"2017-03-14","primary_completion_date_type":"ACTUAL","completion_date":"2017-03-14","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["TAK"]}